Trending

US biotech

PureTech licenses ‘bacterial cocktail’ to boost cancer immunotherapy

PureTech licenses ‘bacterial cocktail’ to boost cancer immunotherapy

PureTech Health is to develop a combination of a microbiome treatment with checkpoint inhibitor immunotherapy to enhance the

X

PureTech licenses ‘bacterial cocktail’ to boost cancer immunotherapy

https://pharmaphorum.com/news/puretech-develop-bacterial-cancer-immunotherapy/

Novartis, BMS, Janssen unveil R&D deals

Novartis, BMS, Janssen unveil R&D deals

Companies announce eye-catching R&D plans ahead of conference.

X

Novartis, BMS, Janssen unveil R&D deals

https://pharmaphorum.com/news/novartis-bms-janssen-jp-morgan/

JP Morgan Healthcare Conference: 7 trends to watch

JP Morgan Healthcare Conference: 7 trends to watch

Taking place this week in San Francisco, the annual JP Morgan Healthcare Conference has become the agenda-setting meeting

X

JP Morgan Healthcare Conference: 7 trends to watch

https://pharmaphorum.com/views-and-analysis/jp-morgan-healthcare-conference-7-trends-to-watch/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com